发明名称 Real Time Management of Data Relating to Physiological Control of Glucose Levels
摘要 Continuous glucose monitoring (CGM) data and insulin delivery data are used to generate more reliable projected alarms related to a projected glucose levels. A memory stores endogenous data related to measurements of glucose level in a patient, and also stores exogenous data, such as insulin on board, both of which are used by a processor to create projected alarms. Profiles of CGM data are created for use in tuning patient-specific insulin data, such at basal rate, carb ratio, and insulin sensitivity. A processor searches for patterns in the data profiles and if found, recommended changes to patient-specific insulin data are provided to permit more accurate control over a patient's glucose levels.
申请公布号 US2014344280(A1) 申请公布日期 2014.11.20
申请号 US201414449691 申请日期 2014.08.01
申请人 Abbott Diabetes Care Inc. 发明人 Wei Charles;Hayter Gary Alan
分类号 G06F17/30;G06F19/00 主分类号 G06F17/30
代理机构 代理人
主权项 1. An integrated glucose management system, comprising: a memory configured to store glucose measurement data, and to store exogenous data including attributes tagged to the stored glucose measurement data; and a processor configured to implement computer-executable instructions to: store the glucose measurement data into the memory during a defined time period;tag the stored glucose measurement data with a corresponding exogenous attribute selected to identify the stored data as associated with a particular category of monitored condition;compare a stored profile to detect a persistent pattern of measured glucose levels in a profile;provide an output if the persistent pattern is detected in the profile; andoutput a recommended change to medication data as a result of the detected persistent pattern;wherein the processor configured to implement the computer-executable instructions is further configured to provide a modification to the medication data; and furtherwherein the processor configured to implement the computer-executable instructions is further configured to prioritize a recommended increase in carbohydrate intake lower than a recommended modification to medication delivery.
地址 Alameda CA US